Answers are grounded in this paper and cite their sources.
It is assumed that a chronic disease progresses from a pre-clinical state to a clinical state. If an individual, having pre-clinical disease, participates in an early detection programme, the disease may be detected in the pre-clinical state. The potential benefit of a screening programme is related to the lead time gained by early diagnosis. A stochastic model is developed for early detection programmes which leads to an estimate of the mean lead time as a function of observable variables. An investigation is also made of a non-progressive disease model in which individuals in a pre-clinical state may not necessarily advance to the clinical state.
No takes yet. Share an insight, caveat, or question.
Zelen et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: